Mitochondrial metabolic dysfunction, either because of down-regulation of the expression of ETC enzymes or mitochondrial membrane translocases, such as TOMM40, may also become an attractive target for the development of agent that delay the stress of the aging process or the initiation and continuation of the damage induced in AD-sensitive neuronal populations. The gene discussed is TOMM40; the disease is Alzheimer disease.